Efficacy and safety of simtuzumab for the treatment of primary sclerosing cholangitis: results of a phase 2b, dose-ranging, randomized, placebo-controlled trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of simtuzumab for the treatment of primary sclerosing cholangitis: results of a phase 2b, dose-ranging, randomized, placebo-controlled trial

16

Citations

0

References

2017

Year

A. Muir, Z. Goodman, Carlos Emílio Levy, Harry Janssen, A.J. Montano-Loza, Christopher L. Bowlus, Dayou Ding, Chunhua Jia, B. Mccolgan, Rob Myers,

Journal of Hepatology

AllergyPhase 2BGastroenterologyPlacebo-controlled TrialCholangiopathiesMedicine

No additional data available for this publication yet. Check back later!